Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 May;11(5):1672-1676.
doi: 10.4103/jfmpc.jfmpc_1599_21. Epub 2022 May 14.

Oral Mucormycosis: An Inevitable Complication of COVID-19

Affiliations
Review

Oral Mucormycosis: An Inevitable Complication of COVID-19

Madhura Dattatraya Kulkarni et al. J Family Med Prim Care. 2022 May.

Abstract

Individuals who have shown recovery from coronavirus disease (COVID-19) are increasingly getting diagnosed with Mucormycosis or "Black fungus." It is a difficult condition to diagnose as it has symptoms that are common among a variety of diseases. Hence, it is important to identify the presenting signs and understand the underlying pathogenesis of COVID-19 associated Mucormycosis. The incidence of these mycotic infections has shown a substantial increase in current times owing to an increase in the prevalence of immunocompromised subjects, human immunodeficiency virus (HIV) infection, and acquired immunodeficiency syndrome (AIDS). Any suspected case of mucormycosis requires rapid diagnosis and management due to its rapid progression as well as the destructive course of infection. This article reviews the taxonomy, pathogenesis, and clinical signs along with laboratory investigations that may play a vital role in the timely diagnosis of this condition as it is mostly fatal.

Keywords: COVID-19; diagnosis; management; mucormycosis; signs.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

Figures

Figure 1
Figure 1
Histopathological picture of necrotic tissue with branching and aseptate fungal hyphae

References

    1. Singh AK, Singh R, Joshi SR, Misra A. Mucormycosis in COVID-19:A systematic review of cases reported worldwide and in India. Diabetes Metab Syndr. 2021;15:102146. - PMC - PubMed
    1. Ribes JC, Vanover-Sans CL. Zygomycetes in human disease. Clin Microbiol Rev. 2000;13:236–301. - PMC - PubMed
    1. Waldorf AR. Pulmonary defense mechanisms against opportunistic fungal pathogens. Immunol Ser. 1989;47:243–71. - PubMed
    1. Waldorf AR, Ruderman N, Diamond RD. Specific susceptibility to mucormycosis in murine diabetes and bronchoalveolar macrophage defense mechanisms against Rhizopus. JClin Invest. 1984;74:150–60. - PMC - PubMed
    1. Bouchara JP, Oumeziane NA, Lissitzky JC, Larcher G, Tronchin G, Chabasse D. Attachment of spores of the human pathogenic fungus Rhizopus oryzae to extracellular matrix components. Eur J Cell Biol. 1996;70:76–83. - PubMed